Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
AntibioticsINJECTIONStandard

BICILLIN C-R

PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE

Standard Dose
300,000 UNITS/ML;300,000 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BICILLIN C-R is listed in Drugs@FDA under application 050138 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE Form and strength INJECTABLE;INJECTION - 300,000 UNITS/ML;300,000 UNITS/ML Sponsor KING PHARMS LLC Submission history Latest submission status date: 2020-12-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview BICILLIN C-R is listed in Drugs@FDA under application 050138 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE Form and strength INJECTABLE;INJECTION - 300,000 UNITS/ML;300,000 UNITS/ML Sponsor KING PHARMS LLC Submission history Latest submission status date: 2020-12-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.